Class II · Moderate riskOngoing Initiated Jul 30, 2021 (5 years ago)
Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Failed Stability Specifications; out of specification for shear.
What was recalled
Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx Only a) 2 Systems NDC 68968-0525-2; b) 8 Systems NDC 68968-0525-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186
Recalling firm
Noven Pharmaceuticals Inc
NDC code
68968-0525-2
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0725-2021
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.